Results 11 to 20 of about 1,159 (113)

Prediction of fetal and neonatal outcomes after preterm manifestations of placental insufficiency: systematic review of prediction models

Ultrasound in Obstetrics &Gynecology, Volume 62, Issue 5, Page 644-652, November 2023., 2023
ABSTRACT Objectives To identify all prediction models for fetal and neonatal outcomes in pregnancies with preterm manifestations of placental insufficiency (gestational hypertension, pre‐eclampsia, HELLP syndrome or fetal growth restriction with its onset before 37 weeks' gestation) and to assess the quality of the models and their performance on ...
D. G. Kleuskens, C. M. C. van Veen, F. Groenendaal, W. Ganzevoort, S. J. Gordijn, B. B. van Rijn, A. T. Lely, E. Schuit, J. Kooiman   +8 more
wiley   +1 more source

Glycosylated fibronectin improves first‐trimester prediction of pre‐eclampsia

Ultrasound in Obstetrics &Gynecology, Volume 62, Issue 4, Page 512-521, October 2023., 2023
ABSTRACT Objective To determine whether maternal serum glycosylated fibronectin (GlyFn) level in the first trimester increases the sensitivity of the Fetal Medicine Foundation (FMF) triple test, which incorporates mean arterial pressure, uterine artery pulsatility index and placental growth factor, when screening for pre‐eclampsia (PE) in an Asian ...
S. Moungmaithong, X. Wang, C. S. L. Lau, A. W. T. Tse, N. M. W. Lee, H. H. Y. Leung, L. C. Poon, D. S. Sahota   +7 more
wiley   +1 more source

Third‐trimester ultrasound for antenatal diagnosis of placenta accreta spectrum in women with placenta previa: results from the ADoPAD study

Ultrasound in Obstetrics &Gynecology, Volume 60, Issue 3, Page 381-389, September 2022., 2022
ABSTRACT Objective To evaluate the performance of third‐trimester ultrasound for the diagnosis of clinically significant placenta accreta spectrum disorder (PAS) in women with low‐lying placenta or placenta previa. Methods This was a prospective multicenter study of pregnant women aged ≥ 18 years who were diagnosed with low‐lying placenta (< 20 mm from
N. Fratelli, F. Prefumo, C. Maggi, C. Cavalli, A. Sciarrone, A. Garofalo, E. Viora, P. Vergani, S. Ornaghi, M. Betti, I. Vaglio Tessitore, A. F. Cavaliere, S. Buongiorno, A. Vidiri, E. Fabbri, E. Ferrazzi, V. Maggi, I. Cetin, T. Frusca, T. Ghi, C. Kaihura, E. Di Pasquo, T. Stampalija, C. Belcaro, M. Quadrifoglio, M. Veneziano, F. Mecacci, S. Simeone, A. Locatelli, S. Consonni, N. Chianchiano, F. Labate, A. Cromi, E. Bertucci, F. Facchinetti, A. Fichera, D. Granata, F. D'Antonio, F. Foti, L. Avagliano, G. P. Bulfamante, G. Calì, the ADoPAD (Antenatal Diagnosis of Placental Adhesion Disorders) Working Group   +42 more
wiley   +1 more source

Routine first‐trimester pre‐eclampsia screening and risk of preterm birth

Ultrasound in Obstetrics &Gynecology, Volume 60, Issue 2, Page 185-191, August 2022., 2022
Abstract Objectives Preterm birth (PTB) is a major public health problem worldwide. It can occur spontaneously or be medically indicated for obstetric complications, such as pre‐eclampsia (PE) or fetal growth restriction. The main objective of this study was to investigate whether there is a shared uteroplacental etiology in the first trimester of ...
V. Giorgione, O. Quintero Mendez, A. Pinas, W. Ansley, B. Thilaganathan   +4 more
wiley   +1 more source

Effect of aspirin on maternal hemodynamics in Chinese women at high risk for preterm pre‐eclampsia: longitudinal study

Ultrasound in Obstetrics &Gynecology, Volume 66, Issue 5, Page 621-630, November 2025.
ABSTRACT Objectives To compare the maternal hemodynamics of Chinese women at low and at high risk for preterm pre‐eclampsia (PE) and assess the differences in hemodynamic parameters between high‐risk women with or without prophylactic aspirin. Methods This was a prospective longitudinal case–control study of 857 Chinese women with a singleton pregnancy
X. Wang, J. Lin, Y. Chen, I. S. Wong, J. Liu, F. Liu, S. L. Lau, Q. Zhang, X. Xu, D. S. Sahota, A. P. W. Lee, L. C. Poon   +11 more
wiley   +1 more source

Screening for pre‐eclampsia using pregnancy‐associated plasma protein‐A or placental growth factor measurements in blood samples collected at 8–14 weeks' gestation

Ultrasound in Obstetrics &Gynecology, Volume 65, Issue 5, Page 567-574, May 2025.
ABSTRACT Objectives To assess the value of pregnancy‐associated plasma protein‐A (PAPP‐A) in screening for preterm pre‐eclampsia (PE) (delivery < 37 weeks' gestation) measured in maternal blood samples collected before 11 weeks, and to compare the screening performance of PAPP‐A with that of placental growth factor (PlGF) from blood samples collected ...
L. Rode, A. Wright, D. Wright, M. Overgaard, L. Sperling, P. Sandager, P. Nørgaard, F. S. Jørgensen, H. Zingenberg, I. Riishede, A. Tabor, C. K. Ekelund, the PRESIDE Study Group, M. R. Andersen, L. Bathum, C. A. Juel Jensen, C. S. Knudsen, N. G. Pedersen, K. Pihl, C. Vedel, H. Skov, S. R. Wagner   +21 more
wiley   +1 more source

Association of maternal body mass index with hemodynamic and vascular alterations at 35–37 weeks' gestation

Ultrasound in Obstetrics &Gynecology, Volume 65, Issue 3, Page 303-310, March 2025.
ABSTRACT Objective Globally, one in four pregnant women is classified as overweight or obese, based on their prepregnancy body mass index (BMI). Obese pregnant women are at increased risk of adverse pregnancy outcomes and long‐term cardiovascular disease that occurs earlier in life.
M. Charakida, C. Chatzakis, L. A. Magee, A. Syngelaki, T. Mansukhani, P. von Dadelszen, K. H. Nicolaides   +6 more
wiley   +1 more source

Prediction of pre‐eclampsia using maternal hemodynamic parameters at 12 + 0 to 15 + 6 weeks

Ultrasound in Obstetrics &Gynecology, Volume 65, Issue 2, Page 173-182, February 2025.
ABSTRACT Objectives To compare the maternal hemodynamic profile at 12 + 0 to 15 + 6 weeks' gestation in women who subsequently developed pre‐eclampsia (PE) and those who did not, and to assess the screening performance of maternal hemodynamic parameters for PE in combination with the Fetal Medicine Foundation (FMF) triple test, including maternal ...
X. Wang, D. S. Sahota, L. Wong, L. Nguyen‐Hoang, Y. Chen, A. S. T. Tai, F. Liu, S. Ling Lau, A. P. W. Lee, L. C. Poon   +9 more
wiley   +1 more source

Intermanufacturer assessment of diagnostic performance of angiogenic ratio vs glycosylated fibronectin in women with suspected pre‐eclampsia

Ultrasound in Obstetrics &Gynecology, Volume 64, Issue 5, Page 620-625, November 2024.
ABSTRACT Objective To compare the diagnostic performance of different manufacturers' immunoassays for the soluble fms‐like tyrosine kinase‐1 (sFlt‐1)‐to‐placental growth factor (PlGF) ratio with that of a point‐of‐care (PoC) test for glycosylated fibronectin (GlyFn) in women with suspected pre‐eclampsia (PE).
I. Y. M. Wah, D. S. Sahota, N. K. L. Wong, N. M. W. Lee, C. J. Liu, C. S. L. Lau, H. H. Y. Leung, L. C. Poon   +7 more
wiley   +1 more source

Postnatal outcome following fetal aortic valvuloplasty for critical aortic stenosis

Ultrasound in Obstetrics &Gynecology, Volume 64, Issue 3, Page 339-347, September 2024.
ABSTRACT Objective To report our experience of fetal aortic valvuloplasty (FAV) for critical aortic stenosis (AS), with a focus on the postnatal evolution of the patients. Methods This was a retrospective study including all fetuses with critical AS which underwent FAV in a single center between January 2011 and June 2022.
R. Corroenne, M. Meot, L. J. Salomon, I. Szezepanski, H. Baghdadi, B. Stos, M. Levy, J. Le Bidois, D. Laux, R. Gaudin, O. Raisky, Y. Ville, D. Bonnet, J. Stirnemann, S. Malekzadeh‐Milani   +14 more
wiley   +1 more source